Respiratory disease in Niemann-Pick type C2 is caused by pulmonary alveolar proteinosis

被引:68
作者
Griese, M. [1 ]
Brasch, F. [2 ]
Aldana, V. R. [3 ]
Cabrera, M. M. [4 ]
Goelnitz, U. [5 ]
Ikonen, E. [6 ]
Karam, B. J. [3 ]
Liebisch, G. [7 ]
Linder, M. D. [6 ]
Lohse, P. [8 ]
Meyer, W. [9 ]
Schmitz, G. [7 ]
Pamir, A. [1 ]
Ripper, J. [1 ]
Rolfs, A. [5 ,10 ]
Schams, A. [1 ]
Lezana, F. J. [3 ]
机构
[1] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany
[2] Klinikum Bremen Mitte, Dept Pathol, Bremen, Germany
[3] Hosp Infantil Mexico Dr Federico Gomez, Dept Pneumol & Resp Physiol, Mexico City, DF, Mexico
[4] Hosp Infantil Mexico Dr Federico Gomez, Dept Pathol, Mexico City, DF, Mexico
[5] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, Fac Med, Rostock, Germany
[6] Univ Helsinki, Inst Biomed Anat, FIN-00014 Helsinki, Finland
[7] Klinikum Univ Regensburg, Inst Klin Chem, D-93053 Regensburg, Germany
[8] Univ Munich, Dept Clin Chem, Munich, Germany
[9] Queen Mary Univ London, St Bartholomews & Royal London Sch Med, London, England
[10] Centogene GmbH, D-18057 Rostock, Germany
关键词
infant; Niemann-Pick type C2; pulmonary alveolar proteinosis; tachypnea; therapeutic lung lavage; COLONY-STIMULATING FACTOR; WHOLE-LUNG LAVAGE; CHOLESTEROL; SURFACTANT; NPC2; MUTATIONS; C1; INVOLVEMENT; TRANSPORT; HE-1;
D O I
10.1111/j.1399-0004.2009.01325.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Niemann-Pick diseases are hereditary neurovisceral lysosomal lipid storage disorders, of which the rare type C2 almost uniformly presents with respiratory distress in early infancy. In the patient presented here, the NPC2 exon 4 frameshift mutation c.408_409delAA caused reduced NPC2 protein levels in serum and lung lavage fluid and the synthesis of an aberrant, larger sized protein of around 28 kDa. Protein expression was strongly reduced also in alveolar macrophages. The infant developed failure to thrive and tachypnea. Lung lavage, computer tomography, and histology showed typical signs of pulmonary alveolar proteinosis with an abnormal intraalveolar accumulation of surfactant as well as macrophages. An NPC2-hypomorph animal model also showed pulmonary alveolar proteinosis and accumulation of macrophages in the lung, liver, and spleen long before the mice died. Due to the elevation of cholesterol, the surfactant had an abnormal composition and function. Despite the removal of large amounts of surfactant from the lungs by therapeutic lung lavages, this treatment was only temporarily successful and the infant died of respiratory failure. Our data indicate that respiratory distress in NPC2 disease is associated with a loss of normal NPC2 protein expression in alveolar macrophages and the accumulation of functionally inactive surfactant rich in cholesterol.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 50 条
  • [31] ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein
    Boadu, Emmanuel
    Nelson, Randy C.
    Francis, Gordon A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (03): : 396 - 404
  • [32] Auditory Phenotype of Niemann-Pick Disease, Type C1
    King, Kelly A.
    Gordon-Salant, Sandra
    Yanjanin, Nicole
    Zalewski, Christopher
    Houser, Ari
    Porter, Forbes D.
    Brewer, Carmen C.
    EAR AND HEARING, 2014, 35 (01) : 110 - 117
  • [33] Function of the Niemann-Pick type C proteins and their bypass by cyclodextrin
    Vance, Jean E.
    Peake, Kyle B.
    CURRENT OPINION IN LIPIDOLOGY, 2011, 22 (03) : 204 - 209
  • [34] Effects of cyclodextrin in two patients with Niemann-Pick Type C disease
    Matsuo, Muneaki
    Togawa, Masami
    Hirabaru, Keiko
    Mochinaga, Sakiko
    Narita, Aya
    Adachi, Masao
    Egashira, Masakazu
    Irie, Tetsumi
    Ohno, Kousaku
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (01) : 76 - 81
  • [35] Consensus clinical management guidelines for Niemann-Pick disease type C
    Geberhiwot, Tarekegn
    Moro, Alessandro
    Dardis, Andrea
    Ramaswami, Uma
    Sirrs, Sandra
    Marfa, Mercedes Pineda
    Vanier, Marie T.
    Walterfang, Mark
    Bolton, Shaun
    Dawson, Charlotte
    Heron, Benedicte
    Stampfer, Miriam
    Imrie, Jackie
    Hendriksz, Christian
    Gissen, Paul
    Crushell, Ellen
    Coll, Maria J.
    Nadjar, Yann
    Kluenemann, Hans
    Mengel, Eugen
    Hrebicek, Martin
    Jones, Simon A.
    Ory, Daniel
    Bembi, Bruno
    Patterson, Marc
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [36] Lysosomal vitamin E accumulation in Niemann-Pick type C disease
    Fernanda Yevenes, Luz
    Klein, Andres
    Francisco Castro, Juan
    Marin, Tamara
    Leal, Nancy
    Leighton, Federico
    Alvarez, Alejandra R.
    Zanlungo, Silvana
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (02): : 150 - 160
  • [37] New Agents and Approaches to Treatment in Niemann-Pick Type C Disease
    Perez-Poyato, Maria S.
    Pineda, Merce
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (06) : 897 - 901
  • [38] Neonatal cholestasis and Niemann-pick type C disease: A literature review
    de Frutos, L. Lopez
    Cebolla, J. J.
    de Castro-Oros, I.
    Irun, P.
    Giraldo, P.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (06)
  • [39] Understanding and Treating Niemann-Pick Type C Disease: Models Matter
    Pallottini, Valentina
    Pfrieger, Frank W.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 37
  • [40] Mitochondrial Cholesterol in Alzheimer's Disease and Niemann-Pick Type C Disease
    Torres, Sandra
    Garcia-Ruiz, Carmen M.
    Fernandez-Checa, Jose C.
    FRONTIERS IN NEUROLOGY, 2019, 10